BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...

October 10, 2023 | News

Agilent & Sarawak Infectious Disease Centre to Enhance Tropical Disease Research in East Malaysia

Neglected tropical diseases (NTDs) are a diverse group of 20 conditions that are mainly prevalent in tropical areas, where they primarily affect impov...

October 09, 2023 | News

Merck Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Carers

Merck, a leading science and technology company, announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to pr...

October 06, 2023 | News

Novavax COVID-19 Vaccine Authorized and Recommended in U.S. for 2023-2024

This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. No...

October 04, 2023 | News

Bausch + Lomb Completes Acquisition of XIIDRA®

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced it h...

October 02, 2023 | News

PHC and JCR Pharma Release Second Update for "Meron Diary" Growth Hormone Treatment App

Jointly developed by PHC IVD and JCR Pharma and released for the first time in October 2020, "Meron Diary" is a smartphone application that can wirelessly ...

October 02, 2023 | News

Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs Sa...

September 29, 2023 | News

BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China

BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...

September 28, 2023 | News

Seven AI/ML Life Sciences Innovators in Clarivate's Watchlist

United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery C...

September 28, 2023 | News

Johnson & Johnson Innovation Collaborates with Singapore EDB to Boost Life Science Innovation

Johnson & Johnson International (Singapore) Pte. Ltd.announced a collaboration with the Singapore Economic Development Board (EDB) to un...

September 26, 2023 | News

GenScript debuts circular RNA and lipid nanoparticles reagent service

Building on GenScript's fast and dependable in-vitro transcription mRNA synthesis service, GenScript now offers the most comprehensive ...

September 20, 2023 | News

Cure Genetics and Frametact Strike $60M Deal for Familial Neurological Disease Gene Therapy

The partnership will leverage Cure Genetics' proprietary VELP™ platform to develop novel Adeno-Associated Virus (AAV) vectors for the treatment of fa...

September 15, 2023 | News

Metabolon Debuts Stress Discovery Panel for Biomarker Detection

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic, therapeutic development, and preci...

September 13, 2023 | News

Serbian Prime Minister Visits SK Bioscience for Vaccine Localization Partnership

Ana Brnabić, Prime Minister of Serbia visited the headquarters of SK bioscience. SK bioscience has signed a Memorandum of Understanding with th...

September 11, 2023 | News

Stay Connected